| 2024/07/17 17:30:08 | |
|---|---|
| Price | |
| 1.20 CHF | |
| Difference | 2.56% (0.03) |
General attributes
| ISIN | CH1251125998 |
| Symbol | RLF |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 14 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 1.16 CHF (1,863) |
| Ask (Ask size) | 1.20 CHF (44,446) |
| Open | 1.15 CHF |
| High | 1.20 CHF |
| Low | 1.15 CHF |
| Close (prev. day) | 1.17 CHF |
| VWAP | 1.15718 CHF |
| Volume (pcs) | 2,628 |
| Trading volume | 3,041.07 |
| Number of trades | 27 |
| Last size | 1 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: RELIEF THERAPEUTICS HOLDING AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/17 17:30:08 | |
|---|---|
| Price | |
| 1.20 CHF | |
| Difference | 2.56% (0.03) |
General attributes
| ISIN | CH1251125998 |
| Symbol | RLF |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 14 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 1.16 CHF (1,863) |
| Ask (Ask size) | 1.20 CHF (44,446) |
| Open | 1.15 CHF |
| High | 1.20 CHF |
| Low | 1.15 CHF |
| Close (prev. day) | 1.17 CHF |
| VWAP | 1.15718 CHF |
| Volume (pcs) | 2,628 |
| Trading volume | 3,041.07 |
| Number of trades | 27 |
| Last size | 1 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -30.64% | -55.72% | -98.28% |
| Perf (abs.) | -0.53 | -1.51 | -68.60 |
| Beta | 0.12 | 0.23 | 0.56 |
| Volatility | 49.23 | 62.94 | 79.27 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 1.19 CHF (9,850) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 1.18 CHF (10,807) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 1.29 CHF (14,269) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 1.77 CHF (17,352) |
| YTD High | date | 1.99 CHF (2024/01/03) |
| YTD Low | date | 1.10 CHF (2024/06/19) |
| 52 Weeks High | date | 4.89 CHF (2023/09/01) |
| 52 Weeks Low | date | 1.10 CHF (2024/06/19) |
All listings for RELIEF THERAPEUTICS HOLDING AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| SIX Swiss Exchange | 2024/07/17 | 17:30 | 1.20 CHF | 0.00 | 27 |
| London Stock Exchange | 2023/09/01 | 17:46 | 4.1412 CHF | 0.02 | 1 |
| FINRA other OTC Issues | 2024/07/17 | 19:00 | 1.35 USD | 0.00 | 4 |
| Berlin | 2019/06/28 | 15:58 | 0.08 EUR | 0.00 | 4 |
Company Logo
Contact Details
| RELIEF THERAPEUTICS HOLDING SA |
| - - |
| Avenue de Sécheron 15 - 1202 Genf |
| Telefon: +41-22-545-11-16 |
| Fax: + |
| E-mail: contact@relieftherapeutics.com |
PDF Downloads
| Company report: RELIEF THERAPEUTICS HOLDING AG | |
Company Profile
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland. |
Members of Management Board
| Andrew Einhorn | Member of Executive Committee |
| Anthony Kim | Member of Executive Committee |
| Giorgio Reiner | Member of Executive Committee |
| Melinda Keegan | Member of Executive Committee |
| Paolo Galfetti | Member of Executive Committee |
| Vincenzo Gallo | Member of Executive Committee |
Board of directors
| Gregory Van Beek | Member of the administrative board |
| Peter Egon de Svastich | Member of the administrative board |
| Tommy Elzinga | Member of the administrative board |
| Raghuram Selvaraju | Chairman of the administrative boar |